Fig. 11From: An Endostatin-lentivirus (ES-LV)-EPC gene therapy agent for suppression of neovascularization in oxygen-induced retinopathy rat modelDetailed flow chart of animal treatment. FFA: fundus fluorescein angiography; HE: hematoxylin-eosin staining; IHC: immunohistochemistry; P: postnatal dayBack to article page